Sales Cambio Fecha
AbbVie USD 14.3B 374M 2023-12
Aceragen USD 2.47M 2.47M 2023-03
Adma Biologics USD 73.9M 6.63M 2023-12
Agenus USD 83.8M 59.49M 2023-12
Amgen USD 8.2B 1.29B 2023-12
AstraZeneca USD 12.02B 532M 2023-12
Biogen USD 2.39B 144M 2023-12
BioMarin Pharmaceutical USD 646.21M 64.88M 2023-12
Bristol-Myers Squibb USD 11.48B 511M 2023-12
Chimerix USD 4K 7K 2023-12
Dynavax Technologies USD 55.6M 13.92M 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
Glaxosmithkline GBP 8.05B 95M 2023-12
Merck USD 14.63B 1.33B 2023-12
Minerva Neurosciences USD 0 0 2021-12
Nektar Therapeutics USD 23.88M 259K 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Novartis USD 11.78B 316M 2023-12
Pfizer USD 14.25B 1.02B 2023-12
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Roche Holding CHF 28.94B 842M 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
TG Therapeutics USD 43.97M 121.84M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



Dynavax Technologies Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.